-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
| Expert: The new crown vaccine has a good protection effect on minors |
China News Service, Guangzhou, July 4 (Reporter Minjie Cai) A seminar on the prevention and control of vaccine-preventable diseases under the new crown epidemic was held in Guangzhou on the 4th
.
Zheng Huizhen, chief expert on disease control of the Guangdong Provincial Preventive Medicine Association, said in an interview during the meeting that the results of the study of healthy children and adolescents vaccinated with the new crown vaccine between the ages of 3 and 17 show that the safety and immunogenicity data are good, and the epidemic situation is serious.
On the evening of June 28, 2021, the World Journal of Infectious Diseases "The Lancet-Infectious Diseases" magazine published online the new coronavirus inactivated vaccine developed by SINOVAC Kexing in healthy children and adolescents aged 3 to 17 The safety, tolerability and immunogenicity of vaccination are the results of a double-blind randomized controlled phase I/II clinical study
.
The results of the study show that among healthy children and adolescents between the ages of 3 and 17, using the 0, 28-day immunization sequence to inoculate two doses of the new crown inactivated vaccine Kellyford, which shows good safety and tolerance to this population Sex, can induce the body to produce a strong humoral immune response
.
The conclusions of the study support the use of 3.
Zheng Huizhen said that the study also found that the immune response of children and adolescents was better than that of adults between 18 and 59 years old and the elderly 60 years old and above after vaccinating two doses of the medium dose (3 micrograms each) according to the same immunization schedule
.
Large-scale vaccination of the new crown virus vaccine is an effective means to build a population's immune barrier and prevent and control the new crown pneumonia epidemic
.
According to statistics, as of 24 June 30, Guangdong has vaccinated 125 041 300 times, a total of 588 7.
7.
Guangdong health committee will be July 1, he said full liberalization over 18 years (including 60 years of age) population vaccinated first dose of inactivated vaccine
.
"The elderly should fight as much as possible
.
" Zheng Huizhen said, unless there are contraindications to vaccination, the elderly who are eligible should receive the new crown pneumonia vaccine as soon as possible
Focus on the new crown pneumonia epidemic
